Literature DB >> 10482454

Imidazothiadiazine dioxides: synthesis and antiviral activity.

A Martínez1, A I Esteban, A Herrero, C Ochoa, G Andrei, R Snoeck, J Balzarini, E De Clercq.   

Abstract

A new series of imidazothiadiazine dioxides, including the first acyclonucleosides derived from this heterocycle moiety, has been synthesized. A wide-spectrum antiviral screening was performed. Some of the N-1 benzyl imidazothiadiazines and the new acyclonucleosides showed interesting anti-CMV or anti-HIV activity. These structures could be considered as new lead compounds for antiviral drug research.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10482454     DOI: 10.1016/s0968-0896(99)00114-5

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

1.  Synthesis, characterization and computational study on potential inhibitory action of novel azo imidazole derivatives against COVID-19 main protease (Mpro: 6LU7).

Authors:  Abhijit Chhetri; Sailesh Chettri; Pranesh Rai; Dipu Kumar Mishra; Biswajit Sinha; Dhiraj Brahman
Journal:  J Mol Struct       Date:  2020-09-18       Impact factor: 3.196

2.  Regioselective synthesis of novel N2- and N4-substituted 7-methylpyrazolo[4,5-e][1,2,4]thiadiazines.

Authors:  Xinyong Liu; Renzhang Yan; Niangen Chen; Wenfang Xu; Maria Teresa Molina; Salvador Vega
Journal:  Molecules       Date:  2006-11-01       Impact factor: 4.411

3.  Crystal structure, Hirshfeld analysis and a mol-ecular docking study of a new inhibitor of the Hepatitis B virus (HBV): ethyl 5-methyl-1,1-dioxo-2-{[5-(pentan-3-yl)-1,2,4-oxa-diazol-3-yl]meth-yl}-2H-1,2,6-thia-diazine-4-carboxyl-ate.

Authors:  Alexandre V Ivachtchenko; Sergiy M Kovalenko; Dmitry V Kravchenko; Oleg D Mitkin; Vladimir V Ivanov; Thierry Langer
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2020-01-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.